Leerink Partners Upgrades Ascendis Pharma (ASND) to Outperform
Tweet Send to a Friend
Leerink Partners analyst Joseph Schwartz upgraded Ascendis Pharma (NASDAQ: ASND) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
